Feyen J H, Kuntzelmann G M
Sandoz Pharma Ltd, Preclinical Research, CH-4002 Basel, Switzerland.
Biochem Biophys Res Commun. 1991 Jul 31;178(2):758-63. doi: 10.1016/0006-291x(91)90173-5.
Okadaic acid (OA), a potent inhibitor of protein phosphatase type 1 and protein phosphatase type 2A was studied for its effect on bone resorption in neonatal mouse calvaria. OA (0.01 to 1000 ng/ml) had no effect on the basal bone resorption rate, except at 1000 ng/ml, were a small inhibitory effect was observed. Resorption stimulated by parathyroid hormone (10(-8) M) was abolished in the presence of OA, half maximal inhibition being observed at 1 ng/ml. However, at 50 ng/ml or higher, OA significantly increased lactate dehydrogenase activity in the medium, indicating a cytotoxic effect at these concentrations. Similar inhibitory effects were observed when bone resorption was stimulated by 1,25-dihydroxycholecalciferol (10(-8) M) or prostaglandin E2 (10(-6) M). From this it is concluded that protein dephosphorylation may represent an important regulatory mechanism in the bone resorption process.
冈田酸(OA)是一种有效的蛋白磷酸酶1型和蛋白磷酸酶2A型抑制剂,研究了其对新生小鼠颅骨骨吸收的影响。OA(0.01至1000 ng/ml)对基础骨吸收速率没有影响,除了在1000 ng/ml时观察到轻微的抑制作用。在OA存在的情况下,甲状旁腺激素(10^(-8) M)刺激的骨吸收被消除,在1 ng/ml时观察到半数最大抑制。然而,在50 ng/ml或更高浓度时,OA显著增加培养基中的乳酸脱氢酶活性,表明在这些浓度下具有细胞毒性作用。当骨吸收由1,25-二羟基胆钙化醇(10^(-8) M)或前列腺素E2(10^(-6) M)刺激时,观察到类似的抑制作用。由此得出结论,蛋白质去磷酸化可能是骨吸收过程中的一种重要调节机制。